Source: Eur Respir J 2014; 43: 554-565
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diel Roland, Vandeputte Joris, de Vries Gerard, Stillo Jonathan, Wanlin Maryse, Nienhaus Albert. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur Respir J 2014; 43: 554-565

Member's Comments

No comment yet.

Related content which might interest you: ERS/ECDC updated European Union standards of tuberculosis care Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 The European Union standards for tuberculosis care: do they need an update? Source: Eur Respir J 2014; 43: 933-942 Year: 2014 Tuberculosis treatment outcome monitoring in European Union countries: systematic review Source: Eur Respir J 2013; 41: 635-643 Year: 2013 Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018 Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care Source: Eur Respir J 2016; 48: 1278-1281 Year: 2016 Cost of scheduled and unscheduled asthma management in seven European Union countries Source: Eur Respir Rev 2006; 15: 4-9 Year: 2006 Tuberculosis: cost of illness in Germany Source: Eur Respir J 2012; 40: 143-151 Year: 2012 Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium Source: Eur Respir J, 51 (5) 1702604; 10.1183/13993003.02604-2017 Year: 2018 Management of tuberculosis in the European Union: a multicentre audit Source: International Congress 2018 – New developments in tuberculosis Year: 2018 Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 The reality of TB lab risks during the national TB program performance. Russian Federation Source: Eur Respir J 2004; 24: Suppl. 48, 198s Year: 2004 Risk factors for death among tuberculosis cases: analysis of European surveillance data Source: Eur Respir J 2008; 31: 1256-1260 Year: 2008 Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study Source: International Congress 2018 – COPD management Year: 2018 Drug-resistant tuberculosis in the European Union and European economic area Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible? Year: 2015 National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update Source: Eur Respir J, 51 (5) 1702678; 10.1183/13993003.02678-2017 Year: 2018 ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update Source: Guideline 2018 Year: 2018 QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study Source: Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018 Year: 2018 Response to RD1 selected epitopes is associated to active tuberculosis. Results of a European multicentre hospital-based study: interim analysis of a European tuberculosis network (TBNET) study Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations Source: Eur Respir J, 52 (5) 1801617; 10.1183/13993003.01617-2018 Year: 2018